Format

Send to

Choose Destination
Cell Rep. 2017 Feb 7;18(6):1444-1457. doi: 10.1016/j.celrep.2017.01.023.

MNK Controls mTORC1:Substrate Association through Regulation of TELO2 Binding with mTORC1.

Author information

1
Department of Neurosurgery, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: mcb52@duke.edu.
2
Department of Neurosurgery, Duke University Medical Center, Durham, NC 27710, USA.

Abstract

The mechanistic target of rapamycin (mTOR) integrates numerous stimuli and coordinates the adaptive response of many cellular processes. To accomplish this, mTOR associates with distinct co-factors that determine its signaling output. While many of these co-factors are known, in many cases their function and regulation remain opaque. The MAPK-interacting kinase (MNK) contributes to rapamycin resistance in cancer cells. Here, we demonstrate that MNK sustains mTORC1 activity following rapamycin treatment and contributes to mTORC1 signaling following T cell activation and growth stimuli in cancer cells. We determine that MNK engages with mTORC1, promotes mTORC1 association with the phosphatidyl inositol 3' kinase-related kinase (PIKK) stabilizer, TELO2, and facilitates mTORC1:substrate binding. Moreover, our data suggest that DEPTOR, the endogenous inhibitor of mTOR, opposes mTORC1:substrate association by preventing TELO2:mTORC1 binding. Thus, MNK orchestrates counterbalancing forces that regulate mTORC1 enzymatic activity.

KEYWORDS:

DDB1; DEPTOR; MNK; PIKK; S6 kinase; T cell; TELO2; mTOR; rapamycin; raptor

PMID:
28178522
PMCID:
PMC5321627
DOI:
10.1016/j.celrep.2017.01.023
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center